Global Rifaximin Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.
LPI (LP Information)' newest research report, the “Rifaximin Industry Forecast” looks at past sales and reviews total world Rifaximin sales in 2022, providing a comprehensive analysis by region and market sector of projected Rifaximin sales for 2023 through 2029. With Rifaximin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rifaximin industry.
This Insight Report provides a comprehensive analysis of the global Rifaximin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rifaximin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rifaximin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rifaximin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rifaximin.
The global Rifaximin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rifaximin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rifaximin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rifaximin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rifaximin players cover Salix Pharmaceuticals. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rifaximin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Rifaximin market?
What factors are driving Rifaximin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rifaximin market opportunities vary by end market size?
How does Rifaximin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.
LPI (LP Information)' newest research report, the “Rifaximin Industry Forecast” looks at past sales and reviews total world Rifaximin sales in 2022, providing a comprehensive analysis by region and market sector of projected Rifaximin sales for 2023 through 2029. With Rifaximin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rifaximin industry.
This Insight Report provides a comprehensive analysis of the global Rifaximin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rifaximin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rifaximin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rifaximin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rifaximin.
The global Rifaximin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rifaximin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rifaximin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rifaximin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rifaximin players cover Salix Pharmaceuticals. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rifaximin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 200 mg Tablets
- 550 mg Tablets
- Hospital
- Drug store
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Salix Pharmaceuticals
What is the 10-year outlook for the global Rifaximin market?
What factors are driving Rifaximin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rifaximin market opportunities vary by end market size?
How does Rifaximin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rifaximin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rifaximin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rifaximin by Country/Region, 2018, 2022 & 2029
2.2 Rifaximin Segment by Type
2.2.1 200 mg Tablets
2.2.2 550 mg Tablets
2.3 Rifaximin Sales by Type
2.3.1 Global Rifaximin Sales Market Share by Type (2018-2023)
2.3.2 Global Rifaximin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rifaximin Sale Price by Type (2018-2023)
2.4 Rifaximin Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Rifaximin Sales by Application
2.5.1 Global Rifaximin Sale Market Share by Application (2018-2023)
2.5.2 Global Rifaximin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rifaximin Sale Price by Application (2018-2023)
3 GLOBAL RIFAXIMIN BY COMPANY
3.1 Global Rifaximin Breakdown Data by Company
3.1.1 Global Rifaximin Annual Sales by Company (2018-2023)
3.1.2 Global Rifaximin Sales Market Share by Company (2018-2023)
3.2 Global Rifaximin Annual Revenue by Company (2018-2023)
3.2.1 Global Rifaximin Revenue by Company (2018-2023)
3.2.2 Global Rifaximin Revenue Market Share by Company (2018-2023)
3.3 Global Rifaximin Sale Price by Company
3.4 Key Manufacturers Rifaximin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rifaximin Product Location Distribution
3.4.2 Players Rifaximin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RIFAXIMIN BY GEOGRAPHIC REGION
4.1 World Historic Rifaximin Market Size by Geographic Region (2018-2023)
4.1.1 Global Rifaximin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rifaximin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rifaximin Market Size by Country/Region (2018-2023)
4.2.1 Global Rifaximin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rifaximin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rifaximin Sales Growth
4.4 APAC Rifaximin Sales Growth
4.5 Europe Rifaximin Sales Growth
4.6 Middle East & Africa Rifaximin Sales Growth
5 AMERICAS
5.1 Americas Rifaximin Sales by Country
5.1.1 Americas Rifaximin Sales by Country (2018-2023)
5.1.2 Americas Rifaximin Revenue by Country (2018-2023)
5.2 Americas Rifaximin Sales by Type
5.3 Americas Rifaximin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rifaximin Sales by Region
6.1.1 APAC Rifaximin Sales by Region (2018-2023)
6.1.2 APAC Rifaximin Revenue by Region (2018-2023)
6.2 APAC Rifaximin Sales by Type
6.3 APAC Rifaximin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rifaximin by Country
7.1.1 Europe Rifaximin Sales by Country (2018-2023)
7.1.2 Europe Rifaximin Revenue by Country (2018-2023)
7.2 Europe Rifaximin Sales by Type
7.3 Europe Rifaximin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rifaximin by Country
8.1.1 Middle East & Africa Rifaximin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rifaximin Revenue by Country (2018-2023)
8.2 Middle East & Africa Rifaximin Sales by Type
8.3 Middle East & Africa Rifaximin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rifaximin
10.3 Manufacturing Process Analysis of Rifaximin
10.4 Industry Chain Structure of Rifaximin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rifaximin Distributors
11.3 Rifaximin Customer
12 WORLD FORECAST REVIEW FOR RIFAXIMIN BY GEOGRAPHIC REGION
12.1 Global Rifaximin Market Size Forecast by Region
12.1.1 Global Rifaximin Forecast by Region (2024-2029)
12.1.2 Global Rifaximin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rifaximin Forecast by Type
12.7 Global Rifaximin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Rifaximin Product Portfolios and Specifications
13.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rifaximin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rifaximin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rifaximin by Country/Region, 2018, 2022 & 2029
2.2 Rifaximin Segment by Type
2.2.1 200 mg Tablets
2.2.2 550 mg Tablets
2.3 Rifaximin Sales by Type
2.3.1 Global Rifaximin Sales Market Share by Type (2018-2023)
2.3.2 Global Rifaximin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rifaximin Sale Price by Type (2018-2023)
2.4 Rifaximin Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Rifaximin Sales by Application
2.5.1 Global Rifaximin Sale Market Share by Application (2018-2023)
2.5.2 Global Rifaximin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rifaximin Sale Price by Application (2018-2023)
3 GLOBAL RIFAXIMIN BY COMPANY
3.1 Global Rifaximin Breakdown Data by Company
3.1.1 Global Rifaximin Annual Sales by Company (2018-2023)
3.1.2 Global Rifaximin Sales Market Share by Company (2018-2023)
3.2 Global Rifaximin Annual Revenue by Company (2018-2023)
3.2.1 Global Rifaximin Revenue by Company (2018-2023)
3.2.2 Global Rifaximin Revenue Market Share by Company (2018-2023)
3.3 Global Rifaximin Sale Price by Company
3.4 Key Manufacturers Rifaximin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rifaximin Product Location Distribution
3.4.2 Players Rifaximin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RIFAXIMIN BY GEOGRAPHIC REGION
4.1 World Historic Rifaximin Market Size by Geographic Region (2018-2023)
4.1.1 Global Rifaximin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rifaximin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rifaximin Market Size by Country/Region (2018-2023)
4.2.1 Global Rifaximin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rifaximin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rifaximin Sales Growth
4.4 APAC Rifaximin Sales Growth
4.5 Europe Rifaximin Sales Growth
4.6 Middle East & Africa Rifaximin Sales Growth
5 AMERICAS
5.1 Americas Rifaximin Sales by Country
5.1.1 Americas Rifaximin Sales by Country (2018-2023)
5.1.2 Americas Rifaximin Revenue by Country (2018-2023)
5.2 Americas Rifaximin Sales by Type
5.3 Americas Rifaximin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rifaximin Sales by Region
6.1.1 APAC Rifaximin Sales by Region (2018-2023)
6.1.2 APAC Rifaximin Revenue by Region (2018-2023)
6.2 APAC Rifaximin Sales by Type
6.3 APAC Rifaximin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rifaximin by Country
7.1.1 Europe Rifaximin Sales by Country (2018-2023)
7.1.2 Europe Rifaximin Revenue by Country (2018-2023)
7.2 Europe Rifaximin Sales by Type
7.3 Europe Rifaximin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rifaximin by Country
8.1.1 Middle East & Africa Rifaximin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rifaximin Revenue by Country (2018-2023)
8.2 Middle East & Africa Rifaximin Sales by Type
8.3 Middle East & Africa Rifaximin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rifaximin
10.3 Manufacturing Process Analysis of Rifaximin
10.4 Industry Chain Structure of Rifaximin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rifaximin Distributors
11.3 Rifaximin Customer
12 WORLD FORECAST REVIEW FOR RIFAXIMIN BY GEOGRAPHIC REGION
12.1 Global Rifaximin Market Size Forecast by Region
12.1.1 Global Rifaximin Forecast by Region (2024-2029)
12.1.2 Global Rifaximin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rifaximin Forecast by Type
12.7 Global Rifaximin Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Rifaximin Product Portfolios and Specifications
13.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rifaximin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rifaximin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 200 mg Tablets
Table 4. Major Players of 550 mg Tablets
Table 5. Global Rifaximin Sales by Type (2018-2023) & (K Units)
Table 6. Global Rifaximin Sales Market Share by Type (2018-2023)
Table 7. Global Rifaximin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rifaximin Revenue Market Share by Type (2018-2023)
Table 9. Global Rifaximin Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Rifaximin Sales by Application (2018-2023) & (K Units)
Table 11. Global Rifaximin Sales Market Share by Application (2018-2023)
Table 12. Global Rifaximin Revenue by Application (2018-2023)
Table 13. Global Rifaximin Revenue Market Share by Application (2018-2023)
Table 14. Global Rifaximin Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Rifaximin Sales by Company (2018-2023) & (K Units)
Table 16. Global Rifaximin Sales Market Share by Company (2018-2023)
Table 17. Global Rifaximin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rifaximin Revenue Market Share by Company (2018-2023)
Table 19. Global Rifaximin Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Rifaximin Producing Area Distribution and Sales Area
Table 21. Players Rifaximin Products Offered
Table 22. Rifaximin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rifaximin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Rifaximin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rifaximin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rifaximin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rifaximin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Rifaximin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rifaximin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rifaximin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rifaximin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Rifaximin Sales Market Share by Country (2018-2023)
Table 35. Americas Rifaximin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rifaximin Revenue Market Share by Country (2018-2023)
Table 37. Americas Rifaximin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Rifaximin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Rifaximin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Rifaximin Sales Market Share by Region (2018-2023)
Table 41. APAC Rifaximin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rifaximin Revenue Market Share by Region (2018-2023)
Table 43. APAC Rifaximin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Rifaximin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Rifaximin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Rifaximin Sales Market Share by Country (2018-2023)
Table 47. Europe Rifaximin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rifaximin Revenue Market Share by Country (2018-2023)
Table 49. Europe Rifaximin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Rifaximin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Rifaximin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Rifaximin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rifaximin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rifaximin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rifaximin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Rifaximin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Rifaximin
Table 58. Key Market Challenges & Risks of Rifaximin
Table 59. Key Industry Trends of Rifaximin
Table 60. Rifaximin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rifaximin Distributors List
Table 63. Rifaximin Customer List
Table 64. Global Rifaximin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Rifaximin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rifaximin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Rifaximin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rifaximin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Rifaximin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rifaximin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Rifaximin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rifaximin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Rifaximin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rifaximin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Rifaximin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rifaximin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Rifaximin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Salix Pharmaceuticals Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 79. Salix Pharmaceuticals Rifaximin Product Portfolios and Specifications
Table 80. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Salix Pharmaceuticals Main Business
Table 82. Salix Pharmaceuticals Latest Developments
Table 1. Rifaximin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rifaximin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 200 mg Tablets
Table 4. Major Players of 550 mg Tablets
Table 5. Global Rifaximin Sales by Type (2018-2023) & (K Units)
Table 6. Global Rifaximin Sales Market Share by Type (2018-2023)
Table 7. Global Rifaximin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rifaximin Revenue Market Share by Type (2018-2023)
Table 9. Global Rifaximin Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Rifaximin Sales by Application (2018-2023) & (K Units)
Table 11. Global Rifaximin Sales Market Share by Application (2018-2023)
Table 12. Global Rifaximin Revenue by Application (2018-2023)
Table 13. Global Rifaximin Revenue Market Share by Application (2018-2023)
Table 14. Global Rifaximin Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Rifaximin Sales by Company (2018-2023) & (K Units)
Table 16. Global Rifaximin Sales Market Share by Company (2018-2023)
Table 17. Global Rifaximin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rifaximin Revenue Market Share by Company (2018-2023)
Table 19. Global Rifaximin Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Rifaximin Producing Area Distribution and Sales Area
Table 21. Players Rifaximin Products Offered
Table 22. Rifaximin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rifaximin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Rifaximin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rifaximin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rifaximin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rifaximin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Rifaximin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rifaximin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rifaximin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rifaximin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Rifaximin Sales Market Share by Country (2018-2023)
Table 35. Americas Rifaximin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rifaximin Revenue Market Share by Country (2018-2023)
Table 37. Americas Rifaximin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Rifaximin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Rifaximin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Rifaximin Sales Market Share by Region (2018-2023)
Table 41. APAC Rifaximin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rifaximin Revenue Market Share by Region (2018-2023)
Table 43. APAC Rifaximin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Rifaximin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Rifaximin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Rifaximin Sales Market Share by Country (2018-2023)
Table 47. Europe Rifaximin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rifaximin Revenue Market Share by Country (2018-2023)
Table 49. Europe Rifaximin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Rifaximin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Rifaximin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Rifaximin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rifaximin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rifaximin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rifaximin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Rifaximin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Rifaximin
Table 58. Key Market Challenges & Risks of Rifaximin
Table 59. Key Industry Trends of Rifaximin
Table 60. Rifaximin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rifaximin Distributors List
Table 63. Rifaximin Customer List
Table 64. Global Rifaximin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Rifaximin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rifaximin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Rifaximin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rifaximin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Rifaximin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rifaximin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Rifaximin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rifaximin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Rifaximin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rifaximin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Rifaximin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rifaximin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Rifaximin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Salix Pharmaceuticals Basic Information, Rifaximin Manufacturing Base, Sales Area and Its Competitors
Table 79. Salix Pharmaceuticals Rifaximin Product Portfolios and Specifications
Table 80. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Salix Pharmaceuticals Main Business
Table 82. Salix Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rifaximin
Figure 2. Rifaximin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rifaximin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rifaximin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rifaximin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 200 mg Tablets
Figure 10. Product Picture of 550 mg Tablets
Figure 11. Global Rifaximin Sales Market Share by Type in 2022
Figure 12. Global Rifaximin Revenue Market Share by Type (2018-2023)
Figure 13. Rifaximin Consumed in Hospital
Figure 14. Global Rifaximin Market: Hospital (2018-2023) & (K Units)
Figure 15. Rifaximin Consumed in Drug store
Figure 16. Global Rifaximin Market: Drug store (2018-2023) & (K Units)
Figure 17. Global Rifaximin Sales Market Share by Application (2022)
Figure 18. Global Rifaximin Revenue Market Share by Application in 2022
Figure 19. Rifaximin Sales Market by Company in 2022 (K Units)
Figure 20. Global Rifaximin Sales Market Share by Company in 2022
Figure 21. Rifaximin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Rifaximin Revenue Market Share by Company in 2022
Figure 23. Global Rifaximin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Rifaximin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Rifaximin Sales 2018-2023 (K Units)
Figure 26. Americas Rifaximin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Rifaximin Sales 2018-2023 (K Units)
Figure 28. APAC Rifaximin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Rifaximin Sales 2018-2023 (K Units)
Figure 30. Europe Rifaximin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Rifaximin Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Rifaximin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Rifaximin Sales Market Share by Country in 2022
Figure 34. Americas Rifaximin Revenue Market Share by Country in 2022
Figure 35. Americas Rifaximin Sales Market Share by Type (2018-2023)
Figure 36. Americas Rifaximin Sales Market Share by Application (2018-2023)
Figure 37. United States Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Rifaximin Sales Market Share by Region in 2022
Figure 42. APAC Rifaximin Revenue Market Share by Regions in 2022
Figure 43. APAC Rifaximin Sales Market Share by Type (2018-2023)
Figure 44. APAC Rifaximin Sales Market Share by Application (2018-2023)
Figure 45. China Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Rifaximin Sales Market Share by Country in 2022
Figure 53. Europe Rifaximin Revenue Market Share by Country in 2022
Figure 54. Europe Rifaximin Sales Market Share by Type (2018-2023)
Figure 55. Europe Rifaximin Sales Market Share by Application (2018-2023)
Figure 56. Germany Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Rifaximin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Rifaximin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Rifaximin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Rifaximin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Rifaximin in 2022
Figure 71. Manufacturing Process Analysis of Rifaximin
Figure 72. Industry Chain Structure of Rifaximin
Figure 73. Channels of Distribution
Figure 74. Global Rifaximin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Rifaximin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Rifaximin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Rifaximin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Rifaximin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Rifaximin Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Rifaximin
Figure 2. Rifaximin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rifaximin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rifaximin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rifaximin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 200 mg Tablets
Figure 10. Product Picture of 550 mg Tablets
Figure 11. Global Rifaximin Sales Market Share by Type in 2022
Figure 12. Global Rifaximin Revenue Market Share by Type (2018-2023)
Figure 13. Rifaximin Consumed in Hospital
Figure 14. Global Rifaximin Market: Hospital (2018-2023) & (K Units)
Figure 15. Rifaximin Consumed in Drug store
Figure 16. Global Rifaximin Market: Drug store (2018-2023) & (K Units)
Figure 17. Global Rifaximin Sales Market Share by Application (2022)
Figure 18. Global Rifaximin Revenue Market Share by Application in 2022
Figure 19. Rifaximin Sales Market by Company in 2022 (K Units)
Figure 20. Global Rifaximin Sales Market Share by Company in 2022
Figure 21. Rifaximin Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Rifaximin Revenue Market Share by Company in 2022
Figure 23. Global Rifaximin Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Rifaximin Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Rifaximin Sales 2018-2023 (K Units)
Figure 26. Americas Rifaximin Revenue 2018-2023 ($ Millions)
Figure 27. APAC Rifaximin Sales 2018-2023 (K Units)
Figure 28. APAC Rifaximin Revenue 2018-2023 ($ Millions)
Figure 29. Europe Rifaximin Sales 2018-2023 (K Units)
Figure 30. Europe Rifaximin Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Rifaximin Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Rifaximin Revenue 2018-2023 ($ Millions)
Figure 33. Americas Rifaximin Sales Market Share by Country in 2022
Figure 34. Americas Rifaximin Revenue Market Share by Country in 2022
Figure 35. Americas Rifaximin Sales Market Share by Type (2018-2023)
Figure 36. Americas Rifaximin Sales Market Share by Application (2018-2023)
Figure 37. United States Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Rifaximin Sales Market Share by Region in 2022
Figure 42. APAC Rifaximin Revenue Market Share by Regions in 2022
Figure 43. APAC Rifaximin Sales Market Share by Type (2018-2023)
Figure 44. APAC Rifaximin Sales Market Share by Application (2018-2023)
Figure 45. China Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Rifaximin Sales Market Share by Country in 2022
Figure 53. Europe Rifaximin Revenue Market Share by Country in 2022
Figure 54. Europe Rifaximin Sales Market Share by Type (2018-2023)
Figure 55. Europe Rifaximin Sales Market Share by Application (2018-2023)
Figure 56. Germany Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Rifaximin Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Rifaximin Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Rifaximin Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Rifaximin Sales Market Share by Application (2018-2023)
Figure 65. Egypt Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Rifaximin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Rifaximin in 2022
Figure 71. Manufacturing Process Analysis of Rifaximin
Figure 72. Industry Chain Structure of Rifaximin
Figure 73. Channels of Distribution
Figure 74. Global Rifaximin Sales Market Forecast by Region (2024-2029)
Figure 75. Global Rifaximin Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Rifaximin Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Rifaximin Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Rifaximin Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Rifaximin Revenue Market Share Forecast by Application (2024-2029)
